zPREDICTA Enters Strategic Collaboration with LabCorp to Advance the Use of 3D Cell Cultures in Research and Drug Development
The collaboration combines zPREDICTA’s strengths in the development of clinically relevant 3D cell culture models with LabCorp’s strengths in drug development and precision medicine